Plaintiffs have brought claims against the makers of YAZ®, Yasmin® and Ocella®, for injuries ranging from internal organ damage (including gallbladder damage), to deep vein thrombosis (or blood clots), stroke, heart attack, myocardial infarction and pulmonary embolism.
A large number of such cases have been designated as Multidistrict Litigation (MDL) cases in the federal courts, to be consolidated for case management and discovery purposes before Judge Herndon the United States District Court for the Southern District of Illinois. In the MDL, on November 12, 2009, the Court appointed attorneys to act as Defendants’ Lead and Liason Counsel, as well as Plaintiffs’ Steering Committee. These select attorneys will be primarily responsible for conducting litigation activities for the consolidated cases.
Stark & Stark’s Mass Tort/Pharmaceutical Litigation Team pursues claims throughout the nation against drug manufacturers, so they can be held accountable when the drugs they market are proven to be defective. If you feel you, or someone you know, have experienced any side-effects from taking YAZ® or Yasmin® contact Stark & Stark to speak to one of the Mass Tort/ Pharmaceutical Litigation attorneys, free of charge, who can help assess any claims that you might have against the YAZ®, Yasmin® or Ocella® manufacturers.